<?xml version="1.0"?>
<!DOCTYPE SupplementalRecordSet SYSTEM "https://www.nlm.nih.gov/databases/dtd/nlmsupplementalrecordset_20170101.dtd">
<SupplementalRecordSet LanguageCode="eng">
    <SupplementalRecord SCRClass="1">
        <SupplementalRecordUI>C114158</SupplementalRecordUI>
        <SupplementalRecordName>
            <String>quantum dye macrocyclic europium-chelate</String>
        </SupplementalRecordName>
        <DateCreated>
            <Year>1998</Year>
            <Month>09</Month>
            <Day>14</Day>
        </DateCreated>
        <DateRevised>
            <Year>2003</Year>
            <Month>08</Month>
            <Day>08</Day>
        </DateRevised>
        <Note>a macrocyclic europium-chelate; structure in first source
        </Note>
        <Frequency>2</Frequency>
        <HeadingMappedToList>
            <HeadingMappedTo>
                <DescriptorReferredTo>
                    <DescriptorUI>*D005063</DescriptorUI>
                    <DescriptorName>
                        <String>Europium</String>
                    </DescriptorName>
                </DescriptorReferredTo>
            </HeadingMappedTo>
            <HeadingMappedTo>
                <DescriptorReferredTo>
                    <DescriptorUI>*D009942</DescriptorUI>
                    <DescriptorName>
                        <String>Organometallic Compounds</String>
                    </DescriptorName>
                </DescriptorReferredTo>
            </HeadingMappedTo>
        </HeadingMappedToList>
        <SourceList>
            <Source>Glycobiology 1998 Sep;8(9):849-56</Source>
        </SourceList>
        <ConceptList>
            <Concept PreferredConceptYN="Y">
                <ConceptUI>M0294520</ConceptUI>
                <ConceptName>
                    <String>quantum dye macrocyclic europium-chelate</String>
                </ConceptName>
                <RegistryNumber>0</RegistryNumber>
                <TermList>
                    <Term ConceptPreferredTermYN="Y" IsPermutedTermYN="N" LexicalTag="NON" RecordPreferredTermYN="Y">
                        <TermUI>T324525</TermUI>
                        <String>quantum dye macrocyclic europium-chelate</String>
                        <ThesaurusIDlist>
                            <ThesaurusID>NLM (1998)</ThesaurusID>
                        </ThesaurusIDlist>
                    </Term>
                    <Term ConceptPreferredTermYN="N" IsPermutedTermYN="N" LexicalTag="NON" RecordPreferredTermYN="N">
                        <TermUI>T324524</TermUI>
                        <String>QD macrocyclic</String>
                        <ThesaurusIDlist>
                            <ThesaurusID>NLM (1998)</ThesaurusID>
                        </ThesaurusIDlist>
                    </Term>
                </TermList>
            </Concept>
        </ConceptList>
    </SupplementalRecord>
    <SupplementalRecord SCRClass="1">
        <SupplementalRecordUI>C008718</SupplementalRecordUI>
        <SupplementalRecordName>
            <String>osteoclast activating factor</String>
        </SupplementalRecordName>
        <DateCreated>
            <Year>1974</Year>
            <Month>01</Month>
            <Day>01</Day>
        </DateCreated>
        <DateRevised>
            <Year>1982</Year>
            <Month>07</Month>
            <Day>28</Day>
        </DateRevised>
        <Note>found in supernatants of cultured human leukocytes; assayed by ability to stimulate bone resorption in
            organ culture in mechanism of localized bone loss
        </Note>
        <Frequency>81</Frequency>
        <HeadingMappedToList>
            <HeadingMappedTo>
                <DescriptorReferredTo>
                    <DescriptorUI>*D008222</DescriptorUI>
                    <DescriptorName>
                        <String>Lymphokines</String>
                    </DescriptorName>
                </DescriptorReferredTo>
            </HeadingMappedTo>
        </HeadingMappedToList>
        <IndexingInformationList>
            <IndexingInformation>
                <DescriptorReferredTo>
                    <DescriptorUI>D001862</DescriptorUI>
                    <DescriptorName>
                        <String>Bone Resorption</String>
                    </DescriptorName>
                </DescriptorReferredTo>
            </IndexingInformation>
            <IndexingInformation>
                <DescriptorReferredTo>
                    <DescriptorUI>D010010</DescriptorUI>
                    <DescriptorName>
                        <String>Osteoclasts</String>
                    </DescriptorName>
                </DescriptorReferredTo>
            </IndexingInformation>
        </IndexingInformationList>
        <SourceList>
            <Source>Ann N Y Acad Sci 230(0):474;1974</Source>
            <Source>Ann N Y Acad Sci 256(0):133;1975</Source>
            <Source>Calcif Tissue Int 1979;29(3):201</Source>
            <Source>Calcif Tissue Res 1979;28(1):23</Source>
            <Source>Cell Immunol 1980;49(1):74</Source>
            <Source>Eur J Immunol 6:732;1976</Source>
            <Source>J Clin Invest 64(1):337;1979</Source>
            <Source>J Exp Med 149(1):279;1979</Source>
            <Source>J Lab Clin Med 92(5):772;1978</Source>
            <Source>Surg Clin North America 57(3):543;1977</Source>
            <Source>WE 200 M486:127;1977</Source>
            <Source>WE 200 M486:13;1977</Source>
            <Source>WE 200 M486:319;1977</Source>
        </SourceList>
        <ConceptList>
            <Concept PreferredConceptYN="Y">
                <ConceptUI>M0052808</ConceptUI>
                <ConceptName>
                    <String>osteoclast activating factor</String>
                </ConceptName>
                <RegistryNumber>64060-24-8</RegistryNumber>
                <TermList>
                    <Term ConceptPreferredTermYN="Y" IsPermutedTermYN="N" LexicalTag="NON" RecordPreferredTermYN="Y">
                        <TermUI>T082811</TermUI>
                        <String>osteoclast activating factor</String>
                        <ThesaurusIDlist>
                            <ThesaurusID>NLM (1974)</ThesaurusID>
                        </ThesaurusIDlist>
                    </Term>
                </TermList>
            </Concept>
        </ConceptList>
    </SupplementalRecord>
    <SupplementalRecord SCRClass="1">
        <SupplementalRecordUI>C008720</SupplementalRecordUI>
        <SupplementalRecordName>
            <String>otoline</String>
        </SupplementalRecordName>
        <DateCreated>
            <Year>1974</Year>
            <Month>01</Month>
            <Day>01</Day>
        </DateCreated>
        <DateRevised>
            <Year>1995</Year>
            <Month>07</Month>
            <Day>21</Day>
        </DateRevised>
        <Note>analog of cpd 48-80; oligomeric product (n-6-8); Russian drug
        </Note>
        <Frequency>0</Frequency>
        <HeadingMappedToList>
            <HeadingMappedTo>
                <DescriptorReferredTo>
                    <DescriptorUI>*D011108</DescriptorUI>
                    <DescriptorName>
                        <String>Polymers</String>
                    </DescriptorName>
                </DescriptorReferredTo>
            </HeadingMappedTo>
        </HeadingMappedToList>
        <IndexingInformationList>
            <IndexingInformation>
                <DescriptorReferredTo>
                    <DescriptorUI>D006636</DescriptorUI>
                    <DescriptorName>
                        <String>Histamine Release</String>
                    </DescriptorName>
                </DescriptorReferredTo>
                <QualifierReferredTo>
                    <QualifierUI>Q000187</QualifierUI>
                    <QualifierName>
                        <String>drug effects</String>
                    </QualifierName>
                </QualifierReferredTo>
            </IndexingInformation>
        </IndexingInformationList>
        <SourceList>
            <Source>Farmakol Toksikol 36(5):614;1973</Source>
        </SourceList>
        <ConceptList>
            <Concept PreferredConceptYN="Y">
                <ConceptUI>M0052812</ConceptUI>
                <ConceptName>
                    <String>otoline</String>
                </ConceptName>
                <RegistryNumber>50643-04-4</RegistryNumber>
                <TermList>
                    <Term ConceptPreferredTermYN="Y" IsPermutedTermYN="N" LexicalTag="NON" RecordPreferredTermYN="Y">
                        <TermUI>T082815</TermUI>
                        <String>otoline</String>
                        <ThesaurusIDlist>
                            <ThesaurusID>NLM (1974)</ThesaurusID>
                        </ThesaurusIDlist>
                    </Term>
                </TermList>
            </Concept>
        </ConceptList>
    </SupplementalRecord>
    <SupplementalRecord SCRClass="1">
        <SupplementalRecordUI>C002540</SupplementalRecordUI>
        <SupplementalRecordName>
            <String>miracil A</String>
        </SupplementalRecordName>
        <DateCreated>
            <Year>1972</Year>
            <Month>01</Month>
            <Day>01</Day>
        </DateCreated>
        <DateRevised>
            <Year>2003</Year>
            <Month>08</Month>
            <Day>08</Day>
        </DateRevised>
        <Note>structure in first source
        </Note>
        <Frequency>1</Frequency>
        <PreviousIndexingList>
            <PreviousIndexing>*ETHYLENEDIAMINES (72-75)</PreviousIndexing>
            <PreviousIndexing>*XANTHENES (72-75)</PreviousIndexing>
        </PreviousIndexingList>
        <HeadingMappedToList>
            <HeadingMappedTo>
                <DescriptorReferredTo>
                    <DescriptorUI>D008154</DescriptorUI>
                    <DescriptorName>
                        <String>Lucanthone</String>
                    </DescriptorName>
                </DescriptorReferredTo>
                <QualifierReferredTo>
                    <QualifierUI>*Q000031</QualifierUI>
                    <QualifierName>
                        <String>analogs &amp; derivatives</String>
                    </QualifierName>
                </QualifierReferredTo>
            </HeadingMappedTo>
        </HeadingMappedToList>
        <SourceList>
            <Source>Prog Drug Res 16:11;1972</Source>
        </SourceList>
        <ConceptList>
            <Concept PreferredConceptYN="Y">
                <ConceptUI>M0043189</ConceptUI>
                <ConceptName>
                    <String>miracil A</String>
                </ConceptName>
                <CASN1Name>9H-Xanthen-9-one, 1-((2-(diethylamino)ethyl)amino)-4-methyl-</CASN1Name>
                <RegistryNumber>3569-84-4</RegistryNumber>
                <TermList>
                    <Term ConceptPreferredTermYN="Y" IsPermutedTermYN="N" LexicalTag="NON" RecordPreferredTermYN="Y">
                        <TermUI>T073192</TermUI>
                        <String>miracil A</String>
                        <ThesaurusIDlist>
                            <ThesaurusID>NLM (1972)</ThesaurusID>
                        </ThesaurusIDlist>
                    </Term>
                </TermList>
            </Concept>
        </ConceptList>
    </SupplementalRecord>
    <SupplementalRecord SCRClass="1">
        <SupplementalRecordUI>C055240</SupplementalRecordUI>
        <SupplementalRecordName>
            <String>Leakadine</String>
        </SupplementalRecordName>
        <DateCreated>
            <Year>1988</Year>
            <Month>04</Month>
            <Day>20</Day>
        </DateCreated>
        <DateRevised>
            <Year>2001</Year>
            <Month>02</Month>
            <Day>06</Day>
        </DateRevised>
        <Note>may contain 2-carbamoylaziridine
        </Note>
        <Frequency>8</Frequency>
        <HeadingMappedToList>
            <HeadingMappedTo>
                <DescriptorReferredTo>
                    <DescriptorUI>*D001388</DescriptorUI>
                    <DescriptorName>
                        <String>Aziridines</String>
                    </DescriptorName>
                </DescriptorReferredTo>
            </HeadingMappedTo>
        </HeadingMappedToList>
        <SourceList>
            <Source>Vopr Onkol 1988;34(2):192</Source>
        </SourceList>
        <ConceptList>
            <Concept PreferredConceptYN="Y">
                <ConceptUI>M0155620</ConceptUI>
                <ConceptName>
                    <String>Leakadine</String>
                </ConceptName>
                <RegistryNumber>91433-16-8</RegistryNumber>
                <TermList>
                    <Term ConceptPreferredTermYN="Y" IsPermutedTermYN="N" LexicalTag="TRD" RecordPreferredTermYN="Y">
                        <TermUI>T185625</TermUI>
                        <String>Leakadine</String>
                        <ThesaurusIDlist>
                            <ThesaurusID>NLM (1988)</ThesaurusID>
                        </ThesaurusIDlist>
                    </Term>
                    <Term ConceptPreferredTermYN="N" IsPermutedTermYN="N" LexicalTag="NON" RecordPreferredTermYN="N">
                        <TermUI>T185624</TermUI>
                        <String>Leakadin</String>
                        <ThesaurusIDlist>
                            <ThesaurusID>NLM (1988)</ThesaurusID>
                        </ThesaurusIDlist>
                    </Term>
                    <Term ConceptPreferredTermYN="N" IsPermutedTermYN="N" LexicalTag="NON" RecordPreferredTermYN="N">
                        <TermUI>T185623</TermUI>
                        <String>Leacadin</String>
                        <ThesaurusIDlist>
                            <ThesaurusID>NLM (1988)</ThesaurusID>
                        </ThesaurusIDlist>
                    </Term>
                </TermList>
            </Concept>
        </ConceptList>
    </SupplementalRecord>
</SupplementalRecordSet>
